ATE413872T1 - Verfahren zur behandlung von inkontinenz - Google Patents

Verfahren zur behandlung von inkontinenz

Info

Publication number
ATE413872T1
ATE413872T1 AT00905786T AT00905786T ATE413872T1 AT E413872 T1 ATE413872 T1 AT E413872T1 AT 00905786 T AT00905786 T AT 00905786T AT 00905786 T AT00905786 T AT 00905786T AT E413872 T1 ATE413872 T1 AT E413872T1
Authority
AT
Austria
Prior art keywords
treating incontinence
incontinence
treating
gamma
instant invention
Prior art date
Application number
AT00905786T
Other languages
English (en)
Inventor
Catherine Segal
Leslie Magnus
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22434891&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE413872(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of ATE413872T1 publication Critical patent/ATE413872T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Seeds, Soups, And Other Foods (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Saccharide Compounds (AREA)
AT00905786T 1999-04-08 2000-01-27 Verfahren zur behandlung von inkontinenz ATE413872T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12834799P 1999-04-08 1999-04-08

Publications (1)

Publication Number Publication Date
ATE413872T1 true ATE413872T1 (de) 2008-11-15

Family

ID=22434891

Family Applications (2)

Application Number Title Priority Date Filing Date
AT00905786T ATE413872T1 (de) 1999-04-08 2000-01-27 Verfahren zur behandlung von inkontinenz
AT08160836T ATE463242T1 (de) 1999-04-08 2000-01-27 Behandlung von inkontinenz

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT08160836T ATE463242T1 (de) 1999-04-08 2000-01-27 Behandlung von inkontinenz

Country Status (13)

Country Link
EP (2) EP1171114B1 (de)
JP (1) JP2002541198A (de)
KR (1) KR20010103053A (de)
AT (2) ATE413872T1 (de)
AU (2) AU779262B2 (de)
CA (1) CA2362026A1 (de)
DE (2) DE60040784D1 (de)
ES (2) ES2313880T3 (de)
HU (1) HUP0200738A3 (de)
IL (1) IL145763A0 (de)
TR (1) TR200102837T2 (de)
WO (1) WO2000061135A1 (de)
ZA (1) ZA200107425B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003088335A (ja) * 2001-09-14 2003-03-25 Pharmafoods Kenkyusho:Kk 排尿機能改善用食品組成物及びそれを含有する飲食品
CA2451267A1 (en) * 2002-12-13 2004-06-13 Warner-Lambert Company Llc Pharmaceutical uses for alpha2delta ligands
PT1572173E (pt) * 2002-12-13 2010-05-10 Warner Lambert Co Ligando alfa-2-delta para tratar sintomas do tracto urinário inferior
CA2510292A1 (en) * 2002-12-20 2004-07-15 Dynogen Pharmaceuticals, Inc. Methods of treating non-painful bladder disorders using .alpha.2.delta. subunit calcium channel modulators
EP1621193A3 (de) * 2002-12-20 2006-08-02 Dynogen Pharmaceuticals Inc. Behandlung nicht-schmerzhafter Blasenstörungen mit Kalziumkanalmodulatoren der alpha2-delta-Untereinheit
KR100742001B1 (ko) * 2003-03-21 2007-07-23 다이노젠 파마세우티컬스, 인코포레이티드 평활근 모듈레이터 및 알파2 델타 서브유닛 칼슘 채널모듈레이터를 이용한 하부 요로 질환의 치료 방법
CA2537837A1 (en) * 2003-09-11 2005-03-24 Xenoport, Inc. Treating and/or preventing urinary incontinence using prodrugs of gaba analogs
CA2541752C (en) 2003-10-14 2012-01-03 Xenoport, Inc. Crystalline form of gamma-aminobutyric acid analog
CN102058885B (zh) * 2006-12-22 2013-04-10 瑞蔻达蒂爱尔兰有限公司 采用α2δ配体和NSAID的下泌尿道疾病的联合治疗
EP2240158A2 (de) * 2007-12-28 2010-10-20 Intas Pharmaceuticals Limited Stabilisierte injizierbare pregabalin-formulierung
WO2009094563A2 (en) 2008-01-25 2009-07-30 Xenoport, Inc. Crystalline form of calcium-salts of (3s)-aminomethyl-b-methyl-hexanoic acids and methods of use
CA2710538A1 (en) 2008-01-25 2009-07-30 Xenoport, Inc. Crystalline form of a (3s)-aminomethyl-5-methyl-hexanoic acid prodrug and methods of use
WO2009094577A2 (en) 2008-01-25 2009-07-30 Xenoport, Inc. Mesophasic forms of (3s)-aminomethyl-5-methyl-hexanoic acid prodrugs and methods of use
ES2423254B1 (es) * 2012-02-15 2014-03-26 Laboratec, S.L. Composición farmacéutica para el tratamiento de incontinencia urinaria y enuresis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992009560A1 (en) * 1990-11-27 1992-06-11 Northwestern University Gaba and l-glutamic acid analogs for antiseizure treatment
DK0641330T3 (da) * 1992-05-20 2001-12-03 Univ Northwestern Gaba- og L-glutaminsyreanaloger til antikrampeanfaldsbehandling
IT1288123B1 (it) * 1996-09-04 1998-09-10 Nicox Sa Uso di nitroderivati per l'incontinenza urinaria
US20020045742A1 (en) * 1998-12-15 2002-04-18 Kenneth A. Jones Dna encoding a gaba b r2 polypeptide and uses thereof

Also Published As

Publication number Publication date
WO2000061135A1 (en) 2000-10-19
HUP0200738A3 (en) 2003-03-28
AU2741600A (en) 2000-11-14
EP1977745B1 (de) 2010-04-07
DE60040784D1 (de) 2008-12-24
AU779262C (en) 2000-11-14
ZA200107425B (en) 2003-02-26
HUP0200738A2 (hu) 2002-07-29
CA2362026A1 (en) 2000-10-19
EP1977745A1 (de) 2008-10-08
EP1171114B1 (de) 2008-11-12
EP1171114A1 (de) 2002-01-16
ES2313880T3 (es) 2009-03-16
ES2341059T3 (es) 2010-06-14
TR200102837T2 (tr) 2002-03-21
IL145763A0 (en) 2002-07-25
AU2005200619A1 (en) 2005-03-10
JP2002541198A (ja) 2002-12-03
KR20010103053A (ko) 2001-11-17
AU779262B2 (en) 2005-01-13
DE60044160D1 (de) 2010-05-20
ATE463242T1 (de) 2010-04-15

Similar Documents

Publication Publication Date Title
DE60040784D1 (de) Verfahren zur behandlung von inkontinenz
DE69535498D1 (de) Verfahren zur behandlung vaskulärer kopfschmerzen
DE69319270D1 (de) Verfahren zur Behandlung von organischen Schlämmen
DE69729946D1 (de) Verwendung von cyclooxygenase-2 inhibitoren zur behandlung und verbeugung von neoplasia
WO2000002546A3 (en) Use of caba-analogues for treating insomnia
DE59807122D1 (de) Verwendung von fumarsäurederivaten zur behandlung von autoimmunerkrankungen
DE60025369D1 (de) Unterchlorige säure enthaltendes superoxidiertes wasser zur behandlung von wunden
ATE259245T1 (de) Verfahren zur behandlung von beweggungsstörungen
ATE250066T1 (de) Verfahren zur reduktion von oxiranyl-epothilonen zu olefinischen epothilonen
DE60122532D1 (de) Verfahren zur behandlung von mehreren bohrlochintervallen
DE69735778D1 (de) Verfahren zur Behandlung von rostfreien Stahlschlacken
DE60023872D1 (de) Verfahren zur erhöhung der biologischen effektivität von zusammensetzungen zur pflanzenbehandlung
ATE331527T1 (de) Verfahren zur behandlung von brustdrüsenerkrankungen
DE69129115D1 (de) Neues verfahren zur behandlung von depression
DE60212613D1 (de) Doxycyclin zur behandlung von akne
DE60106178D1 (de) Verfahren zur Isolierung von hochgereinigten ungesättigten Fettsäuren mittels Kristallisation
ATA17552001A (de) Verfahren zur behandlung säurehältiger abwässer
DE60035326D1 (de) Verfahren zur Behandlung von Abwasser
PL344580A1 (en) Aza-heterocyclic compounds used to treat neurological disorders and hair loss
DE59209268D1 (de) Verfahren zur thermochemisch-thermischen behandlung von einsatzstählen
ATE368110T1 (de) Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten
EP1200538A4 (de) Verfahren zur behandlung von petroleumsäuren
DE59908511D1 (de) Verfahren zur peroxidischen Behandlung von Olefinpolymerisaten
DE69524479D1 (de) Verfahren zur Behandlung von sauren Abgasen
DE69736180D1 (de) Behandlung von manischen erkrankungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties